ITP

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

The DART Study- Daratumumab Treatment in ITP

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP

Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia

Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Anti-BCMA CAR T-Cell Therapy for R/R ITP

Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia

Gut Microbiota in ITP

The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)

Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone